ICH M13A (IR BE) [BE/BA News]

posted by dshah  – India/United Kingdom, 2023-01-17 13:02 (521 d 11:41 ago) – Posting: # 23426
Views: 3,620

Hi Rasha_J!

Below information might be helpful:

"stakeholders from ICH Member countries/regions are encouraged to submit their comments to their respective Regulatory Authorities, noting the deadline for comments indicated beneath each draft Guideline.

Stakeholders can also provide their comments by e-mailing the ICH Secretariat at [email protected]. For this purpose please make sure to use the ICH Template in Excel format. https://admin.ich.org/sites/default/files/2020-12/ICH_PublicConsultationComments_Template_Stakeholders_2020_1014.xlsx

Please note that comments provided to the ICH Secretariat will be shared with the appointed participants of the relevant ICH Working Group responsible for the development of draft documents submitted to consultation."

Regrards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,663 registered users;
38 visitors (0 registered, 38 guests [including 7 identified bots]).
Forum time: 01:43 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5